78.97
전일 마감가:
$79.85
열려 있는:
$79.71
하루 거래량:
268.90K
Relative Volume:
0.18
시가총액:
$9.32B
수익:
$12.50B
순이익/손실:
$314.00M
주가수익비율:
32.37
EPS:
2.44
순현금흐름:
$421.00M
1주 성능:
-1.29%
1개월 성능:
+10.19%
6개월 성능:
+20.07%
1년 성능:
+4.93%
헨리 샤인 Stock (HSIC) Company Profile
명칭
Henry Schein Inc
전화
(631) 843-5500
주소
135 DURYEA RD, MELVILLE, NY
HSIC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
HSIC
Henry Schein Inc
|
78.97 | 9.32B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
MCK
Mckesson Corporation
|
599.51 | 77.79B | 330.19B | 2.54B | 4.31B | 19.31 |
![]()
COR
Cencora Inc
|
247.97 | 47.73B | 293.96B | 1.51B | 3.00B | 7.51 |
![]()
CAH
Cardinal Health Inc
|
128.04 | 30.95B | 222.16B | 1.31B | -486.00M | 5.36 |
![]()
PDCO
Patterson Companies Inc
|
31.02 | 2.72B | 6.55B | 155.22M | -823.13M | 1.71 |
헨리 샤인 Stock (HSIC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-01-06 | 업그레이드 | BofA Securities | Underperform → Buy |
2024-12-04 | 개시 | Mizuho | Neutral |
2024-07-22 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2024-02-26 | 개시 | Leerink Partners | Market Perform |
2023-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
2023-11-10 | 업그레이드 | Stifel | Hold → Buy |
2022-08-08 | 업그레이드 | UBS | Sell → Neutral |
2022-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
2022-06-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2022-05-13 | 재개 | Credit Suisse | Outperform |
2022-01-31 | 개시 | Morgan Stanley | Underweight |
2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
2021-10-01 | 재개 | Credit Suisse | Neutral |
2021-02-08 | 재개 | Piper Sandler | Overweight |
2021-01-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2020-11-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
2020-04-07 | 업그레이드 | Goldman | Neutral → Buy |
2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2020-01-09 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
2020-01-02 | 업그레이드 | Evercore ISI | Underperform → In-line |
2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2019-05-30 | 개시 | Wolfe Research | Underperform |
2019-05-15 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2019-04-18 | 개시 | Guggenheim | Buy |
2019-01-17 | 개시 | UBS | Sell |
2019-01-03 | 다운그레이드 | Evercore ISI | In-line → Underperform |
2019-01-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2018-11-08 | 재확인 | Barrington Research | Outperform |
2018-10-25 | 다운그레이드 | Edward Jones | Hold → Sell |
2018-10-19 | 재개 | Goldman | Neutral |
2018-10-04 | 재확인 | Robert W. Baird | Outperform |
2018-08-07 | 재확인 | Stifel | Hold |
2018-04-24 | 다운그레이드 | Goldman | Buy → Neutral |
2018-04-04 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
모두보기
헨리 샤인 주식(HSIC)의 최신 뉴스
Henry Schein, Inc. (NASDAQ:HSIC) Receives $80.10 Average Target Price from Analysts - MarketBeat
Barrington Research Comments on Henry Schein FY2026 Earnings - MarketBeat
NAW Dirk Van Dongen Lifetime Achievement Award given to Stanley M. Bergman - Fire & Safety Journal Americas
Private Management Group Inc. Buys 18,882 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein Acquires Acentus to Expand Homecare Solutions - The Healthcare Technology Report.
Henry Schein CEO honored - HME News
Henry Schein Medical Honors Women Trailblazers in Athletic Training on National Girls and Women in Sports Day 2025 - Business Wire
Henry Schein, Inc. (NASDAQ:HSIC) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
U.S. private equity firm KKR becomes largest non-index fund shareholder in Henry Schein - Oral Health
SPP Dental Partners & Henry Schein Host Exclusive Dental Marketing Summit in Del Mar, CA on April 25, 2025 - EIN News
Dentsply Sirona, Colgate, Henry Schein among 500 U.S. companies recognized by Newsweek for sustainability - Oral Health
Velir Reimagines Henry Schein One's Digital Experience with Cutting-Edge Optimizely Implementation - Morningstar
UBS Adjusts Price Target on Henry Schein to $83 From $73, Maintains Neutral Rating - Marketscreener.com
Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Pacer Advisors Inc. - Defense World
Cibc World Market Inc. Purchases 9,954 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Barrington Research Cuts Earnings Estimates for Henry Schein - MarketBeat
Henry Schein (NASDAQ:HSIC) Trading 6.2% HigherHere's What Happened - MarketBeat
Henry Schein Completes Acquisition of Acentus - Zenopa
Henry Schein (NASDAQ:HSIC) Price Target Raised to $90.00 at Barrington Research - MarketBeat
Leerink Partnrs Reduces Earnings Estimates for Henry Schein - MarketBeat
KBC Group NV Has $10.25 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Everett Harris & Co. CA Buys 8,015 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
KKR builds stake in Henry Schein, reaches deal to add board seats - MSN
Henry Schein (NASDAQ:HSIC) Updates Q4 2024 Earnings Guidance - MarketBeat
Swedbank AB Has $50.40 Million Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein (NASDAQ:HSIC) Releases FY 2024 Earnings Guidance - MarketBeat
Barrington Research Raises Henry Schein (NASDAQ:HSIC) Price Target to $90.00 - Defense World
Henry Schein Announces Strategic Partnership Agreement with KKR: Board Changes and Financial Results - Defense World
Barrington Research Estimates Henry Schein Q1 Earnings - Defense World
Henry Schein Gains $250M Investment From KKR, Strengthens Growth Strategy - Dentistry Today
Mizuho raises Henry Schein stock target to $78, keeps neutral stance - MSN
Clear Aligners Market on Track for Strong Growth by 2031 | Henry Schein, Inc., TP Orthodontics, Inc., DynaFlex. - openPR
Kirkland Advises KKR on Strategic Investment in Henry Schein - Legal Desire News Network
KKR To Become 12% Shareholder In Henry Schein With Additional $250M Investment: Retail Cheers The Deal - MSN
What Analysts Are Saying About Henry Schein Stock - Benzinga
Henry Schein announces KKR investment, prelim. Q4 sales (update) - MSN
Barrington Research Adjusts Henry Schein Price Target to $90 From $82 -January 30, 2025 at 09:11 am EST - Marketscreener.com
Jefferies Adjusts Henry Schein Price Target to $87 From $80 -January 30, 2025 at 09:10 am EST - Marketscreener.com
American KKR acquired 12% stake in Henry Schein medical company - AK&M News
With its stake in Henry Schein, KKR pushes shared ownership of public companies - ImpactAlpha
Root Canal Files Market Growth in Future Scope 2025-2032 | Henry - openPR
Henry Schein gets $250 million investment from private equity firm KKR - Newsday
KKR to acquire 12% stake in Henry Schein - MSN
Henry Schein gains as KKR reportedly builds stake - MSN
Henry Schein Partners with KKR for Strategic Growth - TipRanks
KKR Builds Stake in Henry Schein With $250M Investment - USA Herald
KKR Plugs $250M Into Healthcare Biz Henry Schein - Law360
Henry Schein, Inc. announced that it expects to receive $250 million in funding from KKR & Co. Inc. - Marketscreener.com
Henry Schein Announces Strategic Investment by KKR - citybiz
KKR builds 12% stake, takes board seats in medical supply company Henry Schein - Axios
헨리 샤인 (HSIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):